Multigene Panel Testing Increases the Number of Loci Associated with Gastric Cancer Predisposition.

CDH1 gene cancer predisposition next-generation sequencing stomach neoplasms

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
11 Sep 2019
Historique:
received: 01 08 2019
revised: 02 09 2019
accepted: 08 09 2019
entrez: 14 9 2019
pubmed: 14 9 2019
medline: 14 9 2019
Statut: epublish

Résumé

The main gene involved in gastric cancer (GC) predisposition is

Identifiants

pubmed: 31514334
pii: cancers11091340
doi: 10.3390/cancers11091340
pmc: PMC6769562
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Pediatr Hematol Oncol. 2014 Aug;36(6):e359-65
pubmed: 24309606
Int J Cancer. 1997 Oct 21;74(5):551-5
pubmed: 9355980
Lancet Gastroenterol Hepatol. 2018 Jul;3(7):489-498
pubmed: 29706558
Semin Oncol. 2016 Oct;43(5):554-559
pubmed: 27899187
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Cancer Genet. 2017 Oct;216-217:111-119
pubmed: 29025585
Fam Cancer. 2016 Apr;15(2):289-96
pubmed: 26700889
Nat Genet. 1998 Dec;20(4):326-8
pubmed: 9843200
J Med Genet. 2015 Jun;52(6):361-74
pubmed: 25979631
Oncotarget. 2017 Jul 18;8(29):47064-47075
pubmed: 28423363
J Pathol. 2013 Mar;229(4):621-9
pubmed: 23208944
BMC Genet. 2001;2:14
pubmed: 11532193
Br J Surg. 2015 Jan;102(1):114-8
pubmed: 25389115
Genomics. 1995 Mar 20;26(2):281-9
pubmed: 7601454
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Cancer Res. 2011 Mar 15;71(6):2222-9
pubmed: 21285249
Hum Mutat. 2008 Nov;29(11):1282-91
pubmed: 18951446
Acta Pathol Microbiol Scand. 1965;64:31-49
pubmed: 14320675
Clin Cancer Res. 2005 Aug 1;11(15):5401-9
pubmed: 16061854
Nature. 1998 Mar 26;392(6674):402-5
pubmed: 9537325
Genes Chromosomes Cancer. 2014 May;53(5):432-45
pubmed: 24493355
Gastroenterol Hepatol Bed Bench. 2011 Fall;4(4):175-85
pubmed: 24834180
Gut. 2004 Jun;53(6):814-20
pubmed: 15138207
Gastroenterology. 2017 Apr;152(5):983-986.e6
pubmed: 28024868
Cancer. 2018 Aug 1;124(15):3145-3153
pubmed: 29750335
J Med Genet. 1999 Dec;36(12):873-80
pubmed: 10593993
Dis Colon Rectum. 2012 Oct;55(10):1038-43
pubmed: 22965402
Gastrointest Endosc. 2018 Feb;87(2):408-418
pubmed: 28688938
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Hum Mutat. 2018 Nov;39(11):1553-1568
pubmed: 30311375
Int J Cancer. 2002 Feb 1;97(4):472-80
pubmed: 11802209
J Med Genet. 2018 Oct;55(10):669-674
pubmed: 29330337
Science. 1999 Dec 3;286(5446):1957-9
pubmed: 10583959
Gut. 2012 May;61(5):774-9
pubmed: 21813476
Hum Mol Genet. 2009 May 1;18(9):1545-55
pubmed: 19168852
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
EMBO J. 1995 Dec 15;14(24):6107-15
pubmed: 8557030
Oncogene. 1996 Dec 19;13(12):2707-16
pubmed: 9000145
BMC Med Genomics. 2015 May 07;8:19
pubmed: 25948282
Eur J Hum Genet. 2017 Nov;25(11):1246-1252
pubmed: 28875981
Gut. 2007 Jul;56(7):965-7
pubmed: 17303595
Am J Hum Genet. 2016 May 5;98(5):830-842
pubmed: 27087319
JAMA Oncol. 2015 Apr;1(1):23-32
pubmed: 26182300
J Med Genet. 2010 Jul;47(7):436-44
pubmed: 20591882
Fam Cancer. 2013 Sep;12(3):503-7
pubmed: 23264079
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Histopathology. 2018 Dec;73(6):878-886
pubmed: 30014492
J Med Genet. 2004 Jul;41(7):508-17
pubmed: 15235021
Lancet Oncol. 2015 Feb;16(2):e60-70
pubmed: 25638682
J Med Genet. 2013 Jul;50(7):486-9
pubmed: 23709761
PLoS Genet. 2014 Oct 23;10(10):e1004669
pubmed: 25340522
JAMA. 2011 Jun 8;305(22):2304-10
pubmed: 21642682
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Gastric Cancer. 2010 Mar;13(1):1-10
pubmed: 20373070
Mol Syndromol. 2017 Jan;8(1):4-23
pubmed: 28232778
Hum Mutat. 2003 Apr;21(4):450
pubmed: 12655570
JAMA. 2007 Jun 6;297(21):2360-72
pubmed: 17545690
Fam Cancer. 2011 Dec;10(4):667-72
pubmed: 21681551
Am J Surg Pathol. 2008 Jun;32(6):799-809
pubmed: 18391748
J Med Genet. 2006 Feb;43(2):138-42
pubmed: 15831593
Hum Mutat. 2007 Feb;28(2):203
pubmed: 17221870
Nat Protoc. 2009;4(7):1073-81
pubmed: 19561590
Hered Cancer Clin Pract. 2011 Sep 21;9(1):9
pubmed: 21936944
Int J Cancer. 2002 Apr 20;98(6):838-43
pubmed: 11948460
Am J Gastroenterol. 2014 Aug;109(8):1159-79
pubmed: 25070057

Auteurs

Gianluca Tedaldi (G)

Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy. gianluca.tedaldi@irst.emr.it.

Francesca Pirini (F)

Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy. francesca.pirini@irst.emr.it.

Michela Tebaldi (M)

Biostatistics and Clinical Trials Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy. michela.tebaldi@irst.emr.it.

Valentina Zampiga (V)

Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy. valentina.zampiga@irst.emr.it.

Ilaria Cangini (I)

Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy. ilaria.cangini@irst.emr.it.

Rita Danesi (R)

Romagna Cancer Registry, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy. rita.danesi@irst.emr.it.

Valentina Arcangeli (V)

Department of Medical Oncology, Ospedale Infermi, 47923 Rimini, Italy. valentina.arcangeli@auslromagna.it.

Mila Ravegnani (M)

Romagna Cancer Registry, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy. mila.ravegnani@irst.emr.it.

Raefa Abou Khouzam (R)

Department of Biology and Biotechnology, University of Pavia, 27100 Pavia, Italy. raefa.aboukhouzam01@universitadipavia.it.

Chiara Molinari (C)

Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy. chiara.molinari@irst.emr.it.

Carla Oliveira (C)

Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), 4200-135 Porto, Portugal. carlaol@ipatimup.pt.
Instituto de Investigação e Inovação em Saúde (i3S), University of Porto, 4200-135 Porto, Portugal. carlaol@ipatimup.pt.
Faculty of Medicine of the University of Porto (FMUP), 4200-319 Porto, Portugal. carlaol@ipatimup.pt.

Paolo Morgagni (P)

Department of General Surgery, Morgagni-Pierantoni Hospital, 47121 Forlì, Italy. morgagni2002@libero.it.

Luca Saragoni (L)

Pathology Unit, Morgagni-Pierantoni Hospital, 47121 Forlì, Italy. luca.saragoni@auslromagna.it.

Maria Bencivenga (M)

Unit of Upper GI Surgery, University of Verona, 37126 Verona, Italy. mariabenci@hotmail.it.

Paola Ulivi (P)

Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy. paola.ulivi@irst.emr.it.

Dino Amadori (D)

Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy. dino.amadori@irst.emr.it.

Giovanni Martinelli (G)

Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy. giovanni.martinelli@irst.emr.it.

Fabio Falcini (F)

Romagna Cancer Registry, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy. fabio.falcini@irst.emr.it.

Guglielmina Nadia Ranzani (GN)

Department of Biology and Biotechnology, University of Pavia, 27100 Pavia, Italy. guglielmina.ranzani@unipv.it.

Daniele Calistri (D)

Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy. daniele.calistri@irst.emr.it.

Classifications MeSH